Find information on thousands of medical conditions and prescription drugs.

Long QT syndrome type 1

The long QT syndrome (LQTS) is a heart disease in which there is an abnormally long delay between the electrical excitation (or depolarization) and relaxation (repolarization) of the ventricles of the heart. It is associated with syncope (loss of consciousness) and with sudden death due to ventricular arrhythmias. Arrhythmias in individuals with LQTS are often associated with exercise or excitement. The cause of sudden cardiac death in individuals with LQTS is ventricular fibrillation. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
Amyotrophic lateral...
Bardet-Biedl syndrome
Labyrinthitis
Lafora disease
Landau-Kleffner syndrome
Langer-Giedion syndrome
Laryngeal papillomatosis
Laryngomalacia
Lassa fever
LCHAD deficiency
Leber optic atrophy
Ledderhose disease
Legg-Calvé-Perthes syndrome
Legionellosis
Legionnaire's disease
Leiomyoma
Leiomyosarcoma
Leishmaniasis
Lemierre's syndrome
Lennox-Gastaut syndrome
Leprechaunism
Leprophobia
Leprosy
Leptospirosis
Lesch-Nyhan syndrome
Leukemia
Leukocyte adhesion...
Leukodystrophy
Leukomalacia
Leukoplakia
LGS
Li-Fraumeni syndrome
Lichen planus
Ligyrophobia
Limb-girdle muscular...
Limnophobia
Linonophobia
Lipodystrophy
Lipoid congenital adrenal...
Liposarcoma
Lissencephaly
Lissencephaly syndrome...
Listeriosis
Liticaphobia
Liver cirrhosis
Lobster hand
Locked-In syndrome
Loiasis
Long QT Syndrome
Long QT syndrome type 1
Long QT syndrome type 2
Long QT syndrome type 3
LSA
Lung cancer
Lupus erythematosus
Lyell's syndrome
Lygophobia
Lyme disease
Lymphangioleiomyomatosis
Lymphedema
Lymphoma
Lymphosarcoma
Lysinuric protein...
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Individuals with LQTS have a prolongation of the QT interval on the ECG. The Q point on the ECG corresponds to the beginning of ventricular depolarization while the T point corresponds to the beginning of ventricular repolarization. The QT interval is measured from the Q point to the end of the T wave. While many individuals with LQTS have persistent prolongation of the QT interval, some individuals do not always show the QT prolongation; in these individuals, the QT interval may prolong with the administration of certain medications.

Genetics

The two most common types of LQTS are genetic and drug-induced. Genetic LQTS can arise from mutation to one of several genes. These mutations tend to prolong the duration of the ventricular action potential (APD), thus lengthening the QT interval. LQTS can be inherited in an autosomal dominant or an autosomal recessive fashion. The autosomal recessive forms of LQTS tend to have a more severe phenotype, with some variants having associated syndactyly or congenital neural deafness. A number of specific genes loci have been identified that are associated with LQTS. Following is a list of the most common mutations:

  • LQT1 - mutations to the alpha subunit of the slow delayed rectifier potassium channel (KvLQT1 or KCNQ1). The current through the heteromeric channel (KvLQT1+minK) is known as IKs. This mutation is thought to cause LQT by reducing the amount of repolarizing action potential current that prolongs action potential duration (APD). These mutations tend to be the most common yet least severe.
  • LQT2 - mutations to the alpha subunit of the fast delayed rectifier potassium channel (HERG + miRP). Current through this channel is known as IKr. This phenotype is also probably caused by a reduction in repolarizing current.
  • LQT3 - mutations to the alpha subunit of the sodium channel (SCN5A). Current through is channel is commonly referred to as INa. Depolarizing current through the channel late in the action potential is thought to prolong APD. The late current is due to failure of the channel to remain inactivated and hence enter a bursting mode in which significant current can enter when it should not. These mutations are more lethal but less common.
  • LQT4 - mutations in an anchor protein Ankyrin B which anchors the ion channels in the cell. Very rare.
  • LQT5 - mutations in the beta subunit MinK which coassembles with KvLQT1.
  • LQT6 - mutations in the beta subunit MiRP1 which coassembles with HERG.
  • LQT7 - mutations in the potassium channel KCNJ2 which leads to Andersen-Tawil syndrome.
  • LQT8 - mutations in the calcium channel Cav1.2 encoded by the gene CACNA1c leading to Timothy's syndrome

Other mutations affect the beta subunits ion channels. For example LQT6 affects minK (aka KCNE1) which is the beta subunit that coassembles with KCNQ1 to form IKs channels.

Read more at Wikipedia.org


[List your site here Free!]


Long QT syndrome
From Alberta RN, 1/1/00 by Elliott, Kari

Recognizing signs of silent killer

It's 7a.m. A 28-year-old woman is wheeled into the emergency room. Her husband explains that she started to have what looked like a seizure when her alarm sounded for work. The young woman is assessed and found to be in stable condition with no apparent history of seizures or syncope. She explains that she gets dizzy during times of stress or exertion. The results of neurological consult are unremarkable.

In this scenario, the patient may be released witbout further diagnostic assessment, cardiac work up or follow up. In fact, she may be suffering from a poorly understood disorder called Long QT Syndrome (LQTS).

I'd like to share what I have learned about LQTS in the hope of reaching some of the front-line staff who may be responsible in assisting doctors during this type of patient scenario. Many cases of LQTS may be misdiagnosed or even missed altogether. The patient's first symptom may in fact be their very last.

LQTS is a disorder of the heart's electrical system, particularly the heart's ability to recharge after a heartbeat, better known as repolarization. The QT interval is a period of time measured by an ECG. The interval represents the period of time in which the heart needs to recharge or repolarize. When the QT interval is prolonged, the patient is vulnerable to ventricular arrhythmia, specifically torsade de point, represented as a sort of twisted helix on the ECG.

The incidence of the disorder is unknown and it is estimated that about one third of patients never develop any symptoms at all. The most common symptoms of LQTS include sudden toss of consciousness and death which tend to occur under physical stress or when startled. Current research suggests that six genes may be responsible for the disorder. A possible link of LQTS to Sudden Infant Death Syndrome is also being explored.

Treatment options include beta blockade therapy to slow conduction of the heart, implanting a pacemaker or internal cardiac defibrillator to override a possibly lethal arrhythmia. In cases such as asthmatics where beta blockade therapy is not recommended, a procedure called a left cervico-thoracic sympathectomy can be performed to remove the nerves that over-stimulate the heart.

Dr. G. Michael Vincent, a professor of medicine at the University of Utah founded the American Sudden Arrhythmia Death Syndrome (SADS) Foundation in 1991. He has been instrumental in forming a Canadian SADS group operating in Toronto. Dr. Vincent's extensive research on LQTS, his desire to educate health care professionals about his findings, to provide support and to increase public awareness of LQTS has no doubt saved many lives.

According to an article published in the 7bronto Star in 1994, Dr. Vincent lists three key points for health care professionals to keep in mind:

* Be aware of unexplained loss of consciousness in children and teens under times of physical exertion or stress.

* When a young person presents with these symptoms, suggest to the attending physician that an ECG be done with special attention to the QT interval.

* If a family member is identified as having LQTS, all members of the family and the extended family should be tested.

Not long after my diagnosis, the founder of the Canadian SADS foundation, Payn Kotsilitis, contacted me. Pam's son died suddenly at the age of 16. Greg had a history of loss of consciousness with startling, particularly when awakened by his alarm for his early-moming paper route. Unfortunately, Greg's last symptom was death.

In August 1999, several of us with varying experiences related to LQTS met in Edmonton to talk about establishing a western Canada chapter of the SADS foundation. The Canadian SADS Foundation in Toronto has been overwhelmingly supportive of our initiative. In October 1999, 1 attended the first annual Canadian SADS conference in Toronto featuring American and Canadian physicians speaking on all aspects of this syndrome. I hope to share what I learn and to support families affected by LQTS in Western Canada.

My encounter with LQTS

My experience with Long QT Syndrome began in October 1995 when my father died suddenly in his early 40s. His family doctor recommended that my siblings and I have a cardiac work up to ensure we did not have any unknown cardiac arrhythmias. In November, Dr. Timothy Prieur tested me on an exercise treadmill, noted a QT prolongation and subsequently referred me to electrophysiologists Dr. Robert Sheldon and Dr. Derek Exner.

In retrospect, there were warning signs during peak activity in my adolescence and stresSful situations such as nursing school. I would get flushed, hate a racing heart. and feel like I was going to faint, It generally subsided on its own when I rested. For Years I blamed hypoglycemia, but according to Dr Derek Exner, hypoglycemia is actually quite rare and often misdiagnosed. My, treatment options were simple. With absence of true syncope or seizures I was put on beta blockade therapy.

When I was diagnosed with LQTS in 1995, 1 was working in family practice. Since then, I have pursued an interest in cardiac nursing and I am currently practising in fix cardiac surgery ward at FoothilL Hospital.

References

SADS website @ www.sads.org. page 1 of "current news" by Dr.G. Michael Vincent AD.

SADS website @ www.sads.org. page 1-4 of "An Overview of the Inherited Long QT Syndrome" by Dr.G.Michael Vincent.

Toronto Star Oct. 10, 1994 by staff reporter Janice Dineen.

The Spectrum of symptoms and QT intervals in carriers of the gene for the Long QT syndrome. Article reprinted from the New England journal of Medicine 327:846-852 (September 17), 1992 authors: Dr.G. Michael Vincent M.D., Katherine W Timothy B.S., Mark Leppert, Ph.D.,and Mark Keating, M.D.

The Sudden infant Death Syndrome and LQ7N. is there a link? summer/fall SADS newsletter, 1999. By Dr. Peter Schwartz M.D. SADS scientific advisor Professor and Chairman Dept of Cardiology, University of Pavia. Pavia, Italy.

EX can provide confirmation of syndrome. Calgary Herald Aug. 27,1999 by staff reporter Susan Scott and Dr. Michael Giuffre M.D. Pediatric Cardiologist. Calgary, Alberta

Copyright Alberta Association of Registered Nurses Jan/Feb 2000
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Long QT syndrome type 1
Home Contact Resources Exchange Links ebay